BioVie Management
Management criteria checks 4/4
BioVie's CEO is Cuong Viet Do, appointed in Apr 2021, has a tenure of 3.58 years. total yearly compensation is $777.08K, comprised of 79.5% salary and 20.5% bonuses, including company stock and options. directly owns 0.51% of the company’s shares, worth $276.74K. The average tenure of the management team and the board of directors is 3.5 years and 6.4 years respectively.
Key information
Cuong Viet Do
Chief executive officer
US$777.1k
Total compensation
| CEO salary percentage | 79.5% |
| CEO tenure | 3.6yrs |
| CEO ownership | 0.5% |
| Management average tenure | 3.5yrs |
| Board average tenure | 6.4yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$27m |
| Jun 30 2024 | US$777k | US$618k | -US$33m |
| Mar 31 2024 | n/a | n/a | -US$37m |
| Dec 31 2023 | n/a | n/a | -US$43m |
| Sep 30 2023 | n/a | n/a | -US$51m |
| Jun 30 2023 | US$2m | US$618k | -US$50m |
| Mar 31 2023 | n/a | n/a | -US$49m |
| Dec 31 2022 | n/a | n/a | -US$41m |
| Sep 30 2022 | n/a | n/a | -US$31m |
| Jun 30 2022 | US$5m | US$300k | -US$26m |
| Mar 31 2022 | n/a | n/a | -US$150m |
| Dec 31 2021 | n/a | n/a | -US$145m |
| Sep 30 2021 | n/a | n/a | -US$143m |
| Jun 30 2021 | US$2m | n/a | -US$184m |
Compensation vs Market: Cuong Viet's total compensation ($USD777.08K) is about average for companies of similar size in the US market ($USD649.07K).
Compensation vs Earnings: Cuong Viet's compensation has been consistent with company performance over the past year.
CEO
Cuong Viet Do (58 yo)
3.6yrs
Tenure
US$777,082
Compensation
Mr. Cuong Viet Do, M.B.A, is Independent Director of Adagene Inc. from November 2022. He serves as the Founder and Chairman at M6P Therapeutics. Mr. Do serves as a Director at Seneca Therapeutics, Inc., si...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.6yrs | US$777.08k | 0.51% $ 276.7k | |
| CFO, Treasurer & Corporate Secretary | 6.1yrs | US$339.25k | 0.085% $ 46.2k | |
| Executive VP of R&D and Chief Medical Officer | 3yrs | US$669.58k | 0.11% $ 60.7k | |
| Senior Vice President of Operations | less than a year | no data | no data | |
| Senior Vice President of Liver Disease Program | no data | no data | no data | |
| Senior Vice President of Manufacturing & Development | 5.8yrs | no data | no data | |
| Senior Vice President of Alzheimer's Disease Program | 3.3yrs | no data | no data |
3.5yrs
Average Tenure
66.5yo
Average Age
Experienced Management: BIVI's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 8.5yrs | US$777.08k | 0.51% $ 276.7k | |
| Independent Director | 5.4yrs | US$156.01k | 0.057% $ 30.7k | |
| Independent Director | 4.4yrs | US$127.19k | 0.035% $ 18.9k | |
| Independent Director | 4.4yrs | US$127.19k | 0.073% $ 39.3k | |
| Independent Chairman | 7.9yrs | US$171.11k | 0.10% $ 54.2k | |
| Independent Director | 7.3yrs | US$164.24k | 0.046% $ 25.1k |
6.4yrs
Average Tenure
65yo
Average Age
Experienced Board: BIVI's board of directors are considered experienced (6.4 years average tenure).